Breaking News Instant updates and real-time market news.

TLRY

Tilray

$141.50

21.3 (17.72%)

, CRON

Cronos Group

$11.43

1.25 (12.28%)

11:04
09/18/18
09/18
11:04
09/18/18
11:04

Cannabis stocks in focus after Tilray gets DEA approval to import cannabis drug

Shares of cannabis stocks are in focus after Canadian marijuana producer Tilray (TLRY) announced approval by the U.S. Drug Enforcement Administration to import a cannabinoid study drug into the U.S. from Canada. DEA APPROVAL: On Tuesday, Tilray announced that the U.S. DEA has granted approval to import a cannabinoid study drug into the U.S. for a clinical trial at the University of California San Diego Center for Medicinal Cannabis Research examining its safety, tolerability and efficacy for Essential Tremor. Tilray is providing a cannabinoid formulation for the trial in capsule form, which will allow researchers to test an investigational drug product containing two active ingredients extracted from the cannabis plant, cannabidiol and tetrahydrocannabinol. The study is expected to begin in early 2019 with financial support from Tilray and the International Essential Tremor Foundation. Essential Tremor is a neurological movement disorder characterized by involuntary and rhythmic shaking. 'PROMOTIONAL AND MISLEADING': Following the announcement, short-seller Citron Research tweeted, "$tlry has now crossed to promotional and misleading They announce that they are supplying cannabis to an already arranged study that does not involve them. No collaboration Low float a promo is a dirty combo for." The tweet comes after Citron announced a short position in Tilray on September 4 via Twitter, saying, "Citron LOVED $TLRY at $26 but now we are SHORTING stock. Cowen lowered est and still raised tgt $62 only shows "RETAIL INVESTORS GONE MAD" and forgot $TLRY went public at $17 - 6 weeks ago. We would expect an equity raise at these levels. By far most expensive in space." Citron also issued a report on September 12, which said, "Since August 15, US marijuana stocks Tilray and Cronos (CRON) have significantly outpaced the performance of their Canadian traded peers. Due to federal regulation, US listed stocks cannot have any operations in the US without losing their listings, whereas Canadian listed stocks can have US operations. The US will be the largest cannabis market in the world. Today, the California market is over 5x larger than all of Canada. Despite obvious logic, we've seen US retail investors pile into the US listed marijuana stocks...Lastly, over the past week Citron has received hundreds of emails from investors ranging from anti-Semitic to threats on family, but NOT one of them could justify the price increases with any analysis whatsoever. We have been publishing for 17 years and this is generally a sign of a retail bubble." WHAT'S NOTABLE: On Monday, Bloomberg reported that Coca-Cola (KO) is monitoring the nascent cannabis drinks industry and is in talks with Canadian marijuana producer Aurora Cannabis (ACBFF) to develop the drinks. Aurora Cannabis announced Tuesday it responded to a request from the Investment Industry Regulatory Organization of Canada regarding reports on potential partnerships with beverage companies. "The company's policy is not to comment on speculative media reports. The company does confirm that it engages in exploratory discussions with industry participants from time to time. At this time the company confirms there is no agreement, understanding or arrangement with respect to any partnership with a beverage company," the company said. CANNABIS STOCKS: Publicly-traded companies in the space include Cronos Group, Canopy Growth (CGC), Tilray, Cannabis Science (CBIS), Innovative Industrial Properties (IIPR) and Aurora Cannabis. PRICE ACTION: Tilray surged roughly 20% to $144.55 in morning trading.

TLRY

Tilray

$141.50

21.3 (17.72%)

CRON

Cronos Group

$11.43

1.25 (12.28%)

KO

Coca-Cola

$46.14

-0.18 (-0.39%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$50.36

1.84 (3.79%)

CBIS

Cannabis Science

$0.00

(0.00%)

IIPR

Innovative Industrial Properties

$44.09

1.12 (2.61%)

  • 13

    Oct

  • 28

    Oct

TLRY Tilray
$141.50

21.3 (17.72%)

09/06/18
09/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ANALYSTS WEIGH IN ON MICRON: Despite recent softness in DRAM spot pricing, the more appropriate metric for Micron Technology (MU) investors to focus on is gross margin, Deutsche Bank analyst Sidney Ho said. On gross margin, the analyst sees Micron benefiting from "solid cost improvement through technology transition" in fiscal 2019. Further, he believes the DRAM market has become more diverse, which should help offset temporary weakness in any given end market. As the company continues to execute on its technology roadmap and delivers solid operating results, Ho expects Micron's stock valuation to re-rate. He kept a Buy rating and $80 price target on Micron. However, Baird analyst Tristan Gerra said Micron is no longer a top large-cap idea, citing its valuation and the likelihood gross margins may be nearing their peak. He also noted DRAM pricing is likely peaking and NAND is in significant oversupply. Gerra maintained an Outperform rating but lowered his price target to $75 from $100 on Micron shares. ARGUS UPGRADES PG&E TO BUY: Argus analyst Jacob Kilstein upgraded PG&E (PCG) to Buy from Hold with a price target of $54, saying the company's recent California legislative victory will reduce its liability for last year's wildfire as its earnings outlook improves. Kilstein further anticipates PG&E to announce a timeline regarding its dividend reinstatement after being forced to suspend its quarterly payout on concerns about its potential wildfire damage responsibility estimated as high as $12B. NORTHLAND DOWNGRADES TILRAY TO MARKET PERFORM: Northland analyst Mike Grondahl downgraded Tilray (TLRY) to Market Perform from Outperform. While he continues to see the company playing a "huge role" in the recreational-use cannabis market in Canada and other countries and the medical market in Europe, he also believes the risk/reward is far more balanced following the recent "massive" move in the stock. JPMORGAN CUTS FRANKLIN RESOURCES TO UNDERWEIGHT: JPMorgan analyst Kenneth Worthington downgraded Franklin Resources (BEN) to Underweight from Neutral and lowered his price target for the shares to $29 from $32. The analyst believes the more recent weakness in emerging markets, and in particular in emerging market debt, will weigh on both Franklin's organic growth and earnings potential. He thinks challenges in emerging markets put additional pressure on "an already challenging growth story characterized by weak fund performance, significant outflows, and declining margins." Worthington continues to have a negative view on the asset management sector.
09/06/18
09/06/18
DOWNGRADE

Market Perform
Tilray downgraded to Market Perform after 'massive' move up at Northland
As previously reported, Northland analyst Mike Grondahl downgraded Tilray to Market Perform from Outperform. While he continues to see the company playing a "huge role" in the recreational-use cannabis market in Canada and other countries and the medical market in Europe, he also believes the risk/reward is far more balanced following the recent "massive" move in the stock. Though he lowered his rating, Grondahl also sees optionality for Tilray from other new markets, including potentially the U.S. someday, he noted.
09/06/18
NORL
09/06/18
DOWNGRADE
NORL
Market Perform
Tilray downgraded to Market Perform from Outperform at Northland
08/29/18
08/29/18
DOWNGRADE
Target $54

Neutral
Tilray downgraded to Neutral on valuation at Roth Capital
As previously reported, Roth Capital analyst Charles Finnie downgraded Tilray (TLRY) to Neutral from Buy, citing valuation, noting that the stock has advanced nearly 2.5 times since going public last month. While Tilray reported strong results and "appears to be on track for a very impressive 2019," Finnie believes the stock's current levels reflect "a highly speculative M&A scenario" following Constellation's (STZ) $4B investment in market leader Canopy Growth (CGC), he tells investors. Though he cut his rating, Finnie raised his price target on Tilray shares to $54 from $35.
CRON Cronos Group
$11.43

1.25 (12.28%)

04/06/18
MITR
04/06/18
UPGRADE
MITR
Buy
Cronos Group upgraded to Buy from Hold at GMP Securities
GMP Securities analyst Martin Landry upgraded Cronos Group to Buy from Hold.
08/15/18
08/15/18
UPGRADE

Hold
Cronos Group upgraded to Hold on 'compelling' new initiatives at Canaccord
As previously reported, Canaccord analyst Matt Bottomley upgraded Cronos Group to Hold from Sell as he believe Cronos has added a number of "compelling" strategic initiatives, such as a supply agreement into Poland's recently legalized medical market; a partnership with MedMen in Canada; the creation of Cronos GrowCo; and the take-or-pay supply agreement with Cura Select of the U.S. Updating for these initiatives lead Bottomley to raise his price target on Cronos shares to C$7.50 from C$6.50.
08/15/18
ADAM
08/15/18
UPGRADE
ADAM
Hold
Cronos Group upgraded to Hold from Sell at Canaccord
05/01/18
ADAM
05/01/18
DOWNGRADE
ADAM
Sell
Cronos Group downgraded to Sell from Hold at Canaccord
KO Coca-Cola
$46.14

-0.18 (-0.39%)

09/04/18
WELS
09/04/18
NO CHANGE
Target $52
WELS
Outperform
Wells Fargo views Coca-Cola acquisition of Costa as 'big opportunity'
Wells Fargo analyst Bonnie Herzog views Coca-Cola's announced acquisition of Costa Limited for $5.1B as "very positive and a big opportunity" for the company over the long-term since she sees it as an accelerator of Coca-Cola's strategy to be the global beverage and coffee leader. Further, the analyst sees this acquisition as solidifying and enhancing CEO Quincey's thoughtful and strategic vision for the company as it doubles Coca-Cola's total addressable market, fills a critical gap in its portfolio, and further builds out its global distribution platform as it executes on its ambition to truly become a Total Beverage company. Herzog reiterates an Outperform rating and $52 price target on the shares.
09/13/18
GUGG
09/13/18
INITIATION
GUGG
Buy
Coca-Cola initiated with a Buy at Guggenheim
09/14/18
GUGG
09/14/18
INITIATION
Target $51
GUGG
Buy
Coca-Cola initiated with a Buy on above consensus growth at Guggenheim
Guggenheim analyst Laurent Grandet initiated Coca-Cola with a Buy and $51 price target and above consensus estimates saying the company is now focused on aggressively innovating across the non-alcoholic beverage space. Grandet sees growth driven by the company's global market leadership in the highly profitable carbonated soft drink segment, rapid and aggressive innovation combined with an acquisition strategy, dominance in on-premise, strength of global Coke bottling system, and an asset light operating model.
09/18/18
STFL
09/18/18
NO CHANGE
Target $66
STFL
Buy
Monster Beverage likely to hike prices regardless of Red Bull, says Stifel
Stifel analyst Mark Astrachan said he still anticipates Monster Beverage will increase prices on its U.S. legacy business, which represents about two-thirds of sales, by about 4% in the fourth quarter of 2018 and raise prices on its brands acquired from Coca-Cola (KO) in the first quarter of 2019 despite industry talks that indicate Red Bull does not currently plan to follow Monster's lead. While noting that he does not view Red Bull's reported lack of current pricing intent as definitive, Astrachan said that should it not follow that he anticipates no material impact to Monster's volume or share trends based on his analysis of the last price increase by both companies in 2015. He maintains a Buy rating and $66 price target on Monster shares.
ACBFF Aurora Cannabis
$0.00

(0.00%)

CGC Canopy Growth
$50.36

1.84 (3.79%)

09/10/18
09/10/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ANALYSTS SEE VALUE IN WYNN FOLLOWING PULLBACK: JPMorgan analyst Joseph Greff argued that there is a disconnect between Wynn Resorts' (WYNN) current operating fundamentals and investor sentiment, viewing the recent sector pullback as a buying opportunity. He kept an Overweight rating on Wynn Resorts with a $191 price target. Sharing a similar opinion, Carlo Santarelli at Deutsche Bank said that he would be a buyer of the stock given current valuation and as conditions in Macau remain stable in both the VIP and mass segments. He kept a Buy rating on Wynn Resorts with a $190 price target. AKAMAI UPGRADED TO BUY: DA Davidson analyst Mark Kelleher upgraded Akamai (AKAM) to Buy from Neutral and raised his price target to $93 from $80 after meeting with its management last week to discuss its Q2 results and the company direction going into 2019. The analyst notes that the discussions boosted his confidence in the company's strategic direction as it executes in a transition to a security vendor, saying the company supported by the "enhanced demand" for its security products over the last few quarters. Kelleher further cites the abating headwinds in the company's media segment, which returned to growth after struggling for the past few quarters. CITI DOWNGRADES ANTHEM, UNITEDHEALTH: Citi analyst Ralph Giacobbe downgraded Anthem (ANTM) and UnitedHealth (UNH) to Neutral with unchanged price targets of $290, and $288, respectively. The analyst is taking a more selective view of the managed care sector into year-end and 2019, citing "some reservations" about the commercial risk market. He sees more limited upside to estimates making it difficult to push valuations meaningfully higher "from already-premium levels." SUNTRUST CUTS CONSTELLATION BRANDS TO HOLD: SunTrust analyst William Chappell downgraded Constellation Brands (STZ) to Hold from Buy and lowered his price target to $220 from $260 while also lowering his FY19 EPS view to $9.35 from $9.59 and FY20 to $10.45 from $10.95. The analyst noted that the company's recent $4B investment in Canopy Growth (CGC) may "keep a cloud" over the stock for the next few quarters, as there is "little certainty" in the deal's revenue or profit potential. Chappell adds that the cannabis business generally has "limited near term catalysts", stating that the stock price may be range bound for an extended time as investors adjust to Constellation Brands' higher leverage ratio. BAIRD DESIGNATES TESLA A FRESH PICK: Baird analyst Ben Kallo designated Tesla (TSLA) as a Fresh Pick as he believes the company's strong fundamentals should drive the shares higher. He said the underlying ramp in Model 3 production will also help push the shares higher ahead of the Q3 deliveries and results. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
08/30/18
STFL
08/30/18
NO CHANGE
STFL
Canopy Growth presentation thorough, but didn't include 'new news,' says Stifel
Stifel analyst Christopher Growe said Canopy Growth's (CGC) investor day presentation provided a thorough introduction to the company, but was "devoid of new news." The Constellation (STZ) partnership dramatically increased interest in the event and he came away impressed with the level of professionalism of the organization, Growe tells investors. Canopy's valuation has been pushed to 19X EV/Sales when considering FY20 consensus estimates and whether this accurately captures Canopy's advantaged position is "open for debate," added Growe.
08/30/18
MSCO
08/30/18
NO CHANGE
Target $258
MSCO
Overweight
Morgan Stanley keeps Overweight on Constellation after 'solid' Canopy meeting
After attending Canopy Growth's (CGC) analyst day, Morgan Stanley analyst Dara Mohsenian said he was impressed by CEO Bruce Linton and the Canopy organization. He also noted that Constellation Brands' (STZ) CFO David Klein clearly remains confident in its beer prospects and indirectly refuted the bear case that its investment in Canopy signals slowing base business growth. Mohsenian, who thinks the risk around the Canopy stake has been more than priced into Constellation shares given their pullback since the deal, also believes the market is not pricing in enough long-term beer revenue growth. He reiterated his Overweight rating and $258 price target on Constellation shares following the investor meetings.
09/04/18
COWN
09/04/18
NO CHANGE
COWN
Outperform
Canopy Growth price target raised to C$74 from C$56 at Cowen
Cowen analyst Vivien Azer met with Canopy Growth (CGC) management and came away convinced on the company's ability to establish an early lead in the adult use cannabis market, as well as domestic and international medical cannabis markets. The company has signed a dominant share of supply agreements and has the capacity to meet both initial and medium-term demand. Canopy Growth's cash infusion from Constellation Brands (STZ) should provide an opportunity to gain an early share lead in international markets, added Azer, who reiterated her Outperform rating on Canopy Growth shares and raised her price target on the stock to C$74.
CBIS Cannabis Science
$0.00

(0.00%)

IIPR Innovative Industrial Properties
$44.09

1.12 (2.61%)

08/14/18
LTCO
08/14/18
NO CHANGE
Target $41
LTCO
Buy
Innovative Industrial Properties target raised to $41 at Ladenburg
Innovative Industrial Properties has remained active deploying capital raised in its January follow-on offering, Ladenburg Thalmann analyst John Massocca tells investors in a research note. With consistent returns on investments and "strong" industry trends in the medical cannabis sector, Innovative Industrial "seems positioned for sector high earnings growth," the analyst adds. He raised his price target for the shares to $41 from $38 and reiterates a Buy rating on the name.
09/10/18
LTCO
09/10/18
NO CHANGE
LTCO
Buy
Innovative Industrial price target raised to $47.50 from $41 at Ladenburg
Ladenburg Thalmann analyst John Massocca raised his price target for Innovative Industrial Properties to $47.50 after spending time with management. The analyst continues to see the Innovative's earnings growth potential as well above that of its single-tenant net lease peers and almost any other publicly traded REIT. He reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

22:45
10/15/18
10/15
22:45
10/15/18
22:45
General news
China's CPI grew 2.5% y/y in September »

China's CPI grew…

PYPL

PayPal

$77.22

-1.8 (-2.28%)

20:49
10/15/18
10/15
20:49
10/15/18
20:49
Recommendations
PayPal analyst commentary at Stifel »

PayPal earnings to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 26

    Nov

ALRM

Alarm.com

$44.50

0.16 (0.36%)

20:45
10/15/18
10/15
20:45
10/15/18
20:45
Upgrade
Alarm.com rating change at First Analysis »

Alarm.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SGBAF

SES S.A.

$0.00

(0.00%)

20:36
10/15/18
10/15
20:36
10/15/18
20:36
Upgrade
SES S.A. rating change at JPMorgan »

SES S.A. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, UNH

UnitedHealth

$259.80

0.36 (0.14%)

20:25
10/15/18
10/15
20:25
10/15/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

UNH

UnitedHealth

$259.80

0.36 (0.14%)

GS

Goldman Sachs

$215.28

1.37 (0.64%)

MS

Morgan Stanley

$43.45

(0.00%)

BLK

BlackRock

$427.40

-0.18 (-0.04%)

PLD

Prologis

$63.00

0.45 (0.72%)

PGR

Progressive

$66.23

-0.64 (-0.96%)

GWW

Grainger

$318.38

6.75 (2.17%)

OMC

Omnicom

$69.48

0.8 (1.16%)

CMA

Comerica

$83.69

-1.04 (-1.23%)

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

DPZ

Domino's Pizza

$273.13

-4.215 (-1.52%)

FHN

First Horizon

$15.99

-0.11 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 27

    Nov

  • 24

    Jan

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

20:13
10/15/18
10/15
20:13
10/15/18
20:13
Recommendations
Twilio, SendGrid analyst commentary at MUFG »

MUFG analyst 'fully…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

20:07
10/15/18
10/15
20:07
10/15/18
20:07
Recommendations
Palo Alto Networks analyst commentary at JPMorgan »

Palo Alto Networks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

SVA

Sinovac Biotech

$7.16

-0.03 (-0.42%)

20:03
10/15/18
10/15
20:03
10/15/18
20:03
Hot Stocks
Sinovac Biotech commences legal proceedings in Hong Kong »

Senior management of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWN

Northwest Natural Gas

$67.70

0.36 (0.53%)

20:01
10/15/18
10/15
20:01
10/15/18
20:01
Hot Stocks
Northwest Natural Water unit to buy Sunriver Water LLC, terms not stated »

NW Natural Water Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VFC

VF Corp.

$87.65

0.11 (0.13%)

19:53
10/15/18
10/15
19:53
10/15/18
19:53
Initiation
VF Corp. initiated at Wedbush »

VF Corp. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

LVS

Las Vegas Sands

$55.84

-0.32 (-0.57%)

19:39
10/15/18
10/15
19:39
10/15/18
19:39
Upgrade
Las Vegas Sands rating change at HSBC »

Las Vegas Sands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$72.24

-4.69 (-6.10%)

19:37
10/15/18
10/15
19:37
10/15/18
19:37
Recommendations
Occidental Petroleum analyst commentary at MUFG »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AVMXY

Avita Medical

$0.00

(0.00%)

19:24
10/15/18
10/15
19:24
10/15/18
19:24
Hot Stocks
Avita Medical announces Recell trial results presentation »

AVITA Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

19:16
10/15/18
10/15
19:16
10/15/18
19:16
Hot Stocks
Facebook confirms expanding policies on voter suppression »

Facebook said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

18:58
10/15/18
10/15
18:58
10/15/18
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: J.B.…

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

SEND

SendGrid

$30.94

0.04 (0.13%)

TWLO

Twilio

$76.26

1.27 (1.69%)

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

ADBE

Adobe

$238.05

-10.84 (-4.36%)

CRY

CryoLife

$30.64

0.42 (1.39%)

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

JELD

Jeld-Wen

$21.31

-0.04 (-0.19%)

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

AGN

Allergan

$183.03

-0.275 (-0.15%)

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

SNAP

Snap

$7.41

0.225 (3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 25

    Oct

  • 30

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 27

    Nov

  • 10

    Dec

SHLD

Sears

$0.31

-0.0901 (-22.52%)

18:43
10/15/18
10/15
18:43
10/15/18
18:43
Hot Stocks
Sears receives court approval of 'first day' motions to support business ops »

Sears Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$97.03

1.63 (1.71%)

18:38
10/15/18
10/15
18:38
10/15/18
18:38
Upgrade
Wabtec rating change at Wellington Shields »

Wabtec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

18:30
10/15/18
10/15
18:30
10/15/18
18:30
Hot Stocks
Tallgrass Energy, Silver Creek Midstream to expand Powder River Basin JV »

Tallgrass Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.47

0.86 (0.76%)

, GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

18:21
10/15/18
10/15
18:21
10/15/18
18:21
Hot Stocks
Disney-backed Jaunt to focus efforts on AR, says some staff will be 'moving on' »

Jaunt, a top-funded VR…

DIS

Disney

$113.47

0.86 (0.76%)

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 08

    Nov

  • 03

    Mar

HMC

Honda

$27.05

-0.16 (-0.59%)

18:19
10/15/18
10/15
18:19
10/15/18
18:19
Hot Stocks
Honda to recall 54 model year 2017-2018 Honda Civic and Honda CR-V vehicles »

American Honda will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MSFT

Microsoft

$107.60

-1.94 (-1.77%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Microsoft co-founder Paul Allen dead at 65 »

Vulcan Inc. released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

OII

Oceaneering

$25.69

0.4 (1.58%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Oceaneering provides update following Hurricane Michael »

Oceaneering International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

JOE

Saint Joe Co.

$15.28

0.01 (0.07%)

18:07
10/15/18
10/15
18:07
10/15/18
18:07
Hot Stocks
Saint Joe released additional information regarding Hurricane Michael »

The St. Joe Company …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.41

0.055 (0.36%)

18:05
10/15/18
10/15
18:05
10/15/18
18:05
Periodicals
Petrobras anticipates reviving TAG sale over next month, Reuters says »

Petrobras expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Hot Stocks
Adobe says it sees increased demand for PDF capabilities »

Says it has over 300,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.